A recent report published by Infinium Global Research on the bacteriophage market provides an in-depth analysis of segments and sub-segments in the global as well as regional bacteriophage market. The study also highlights the impact of drivers, restraints, and macro indicators on the global and regional bacteriophage market over the short term as well as long term. The report is a comprehensive presentation of trends, forecast and dollar values of the global bacteriophage market. According to the report, the global bacteriophage market is projected to grow at a CAGR of 4.3% over the forecast period of 2020-2026.

Market Insight

A bacteriophage is a virus that infects and replicates within archaea and bacteria. These are composed of a nucleic acid molecule surrounded by a protein structure. It attracts itself to a susceptible bacterium and infects the host cell. It prevents it from producing bacterial components. Bacteriophages can infect and kill bacteria without any negative effect on animal or human cells. Bacteriophages are anticipated as the most widely distributed and varied entities in the biosphere. Nowadays, their potential to be utilized as phage display systems, antibacterial, vehicles for vaccines and biocontrol agents, and the attention towards bacteriophage is rekindled.

Additionally, the current concern over the spread of coronavirus is also expected to have a negative impact on the bacteriophage market. The enforced quarantine in China, India, and many other countries has hit the supply-chain hardest as these countries have transitioned from being a key player in the bacteriophage market. Governments globally implemented quarantine and travel limitations to curb the spread of the COVID-19 pandemic; however, such measures threaten industrial operation. Together with temporary shutdowns in some countries, the bacteriophage industry also faces severe consequences of supply chain disruptions.

Bacteriophages are an efficient tool used in modern biotechnology through several types of research to advocate the potential usage of bacteriophages in various applications. The rising use of biocontrol agents in the petroleum and agriculture industry will augment the growth of the bacteriophage market. The increasing research and development funding for investigating bacteriophage therapy in clinical applications boosts the growth of the bacteriophage market. Further, bacteriophages are used as vaccine vehicles for detecting pathogenic bacterial strain complement market growth. The growing demand for bacteriophages as display systems in various antibodies and proteins stimulate the development of the bacteriophage market. In addition, bacteriophages are a diverse group of viruses that can be manipulated and thus have applications in research, therapeutics, and biotechnology. Furthermore, the increasing adoption of bacteriophages in food biopreservation, corrosion control, biofilm control, bacterial biosensing services, and phage-display based selection of biological affinity led to the growth of the market. On the flip side, the high cost for therapy of bacteriophage therapy hinders the growth of the bacteriophage market. Moreover, increasing research for the establishment of bacteriophage as an effective vaccine delivery system creates growth opportunities for the bacteriophage market.

Geographically, the global bacteriophage market is divided into North America, Asia-Pacific, Europe, and the Rest of the World. North America is expected to have the largest share in the global bacteriophage market. The well-established research infrastructure, strong desire to overcome the burden of antibiotic-resistant infections, and the existence of a potential pipeline for phase therapy in North America contribute to the growth of the bacteriophage market in North America. Europe is anticipated to grow with a healthy CAGR in the global bacteriophage market over the forecast period. The rising application of bacteriophage in food and environmental field in Europe drive the expansion of bacteriophage market in the region. Asia-Pacific region has the fastest growth rate in the global bacteriophage market owing to the rapid evolution of biotechnology infrastructure and rising supportive initiatives from the government in the region.

Segment Covered

The report on the global bacteriophage market covers segments such as type, and application. On the basis of type, the sub-markets include dsDNA Bacteriophage, ssDNA Bacteriophage, and ssRNA bacteriophage. On the basis of application, the sub-markets include clinical application, phage display, environmental application, veterinary, and phage therapy.

Companies Profiled:

The report provides profiles of the companies in the market such as Phage Biotech Ltd., Fixed-Phage Limited, InnoPhage Ltd., EnBiotix Inc., Pherecydes Pharma SA, TechnoPhage SA, Versatile Bio Fuels Pvt. Ltd., Federal State Scientific Industrial Company MICROGEN, Intralytix, Inc., and AmpliPhi Biosciences Corporation.

Report Highlights:

The report provides deep insights into the demand forecasts, market trends, and micro and macro indicators. In addition, this report provides insights into the factors that are driving and restraining the growth in this market. Moreover, The IGR-Growth Matrix analysis given in the report brings an insight into the investment areas that existing or new market players can consider. The report provides insights into the market using analytical tools such as Porter's five forces analysis and DRO analysis of the bacteriophage market. Moreover, the study highlights current market trends and provides forecast from 2020-2026. We also have highlighted future trends in the market that will affect the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight into the market share of the leading players.